Illumina CEO Talks Future of Array Market, Manufacturing Expansion at UBS Conference

The array market is set to grow to $900 million by 2013 and Illumina hopes to capture its share with next-generation genotyping arrays for future GWAS. But high demand for the firm's chips and instruments has led to manufacturing constraints that it is now working to overcome.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.